D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Netflix
NFLX
|
+$427M |
| 2 |
NXP Semiconductors
NXPI
|
+$267M |
| 3 |
Medtronic
MDT
|
+$245M |
| 4 |
Gilead Sciences
GILD
|
+$244M |
| 5 |
Hewlett Packard
HPE
|
+$213M |
Top Sells
| 1 |
Amazon
AMZN
|
+$406M |
| 2 |
CVS Health
CVS
|
+$381M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$307M |
| 5 |
VMW
VMware, Inc
VMW
|
+$268M |
Sector Composition
| 1 | Technology | 14.04% |
| 2 | Healthcare | 13.47% |
| 3 | Financials | 11.87% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CACB
2101
DELISTED
Cascade Bancorp
CACB
| $393K | ﹤0.01% |
48,411
-2,288
| -5% | -$18.6K |
|
2102
NETSCOUT
NTCT
$1.8B
| $391K | ﹤0.01% |
12,422
-17,291
| -58% | -$544K |
|
2103
Talphera
TLPH
$17.4M
| $390K | ﹤0.01% |
7,507
-4,346
| -37% | -$226K |
|
2104
Karyopharm Therapeutics
KPTI
$53.8M
| $387K | ﹤0.01% |
2,751
+870
| +46% | +$122K |
|
2105
Forum Energy Technologies
FET
$325M
| $386K | ﹤0.01% |
877
-3,954
| -82% | -$1.74M |
|
2106
Skywest
SKYW
$4.37B
| $386K | ﹤0.01% |
10,603
-4,100
| -28% | -$149K |
|
2107
MBIA
MBI
$374M
| $384K | ﹤0.01% |
+35,845
| New | +$384K |
|
2108
Lifecore Biomedical
LFCR
$262M
| $383K | ﹤0.01% |
27,760
+11,371
| +69% | +$157K |
|
|
BFX
2109
DELISTED
BowFlex Inc.
BFX
| $383K | ﹤0.01% |
20,713
-18,270
| -47% | -$338K |
|
2110
Kadant
KAI
$3.75B
| $381K | ﹤0.01% |
6,221
+1,077
| +21% | +$66K |
|
2111
Teledyne Technologies
TDY
$25.6B
| $381K | ﹤0.01% |
+3,094
| New | +$381K |
|
|
JWN
2112
DELISTED
Nordstrom
JWN
| $379K | ﹤0.01% |
7,910
-43,879
| -85% | -$2.1M |
|
2113
Power Integrations
POWI
$2.5B
| $376K | ﹤0.01% |
11,076
-2,776
| -20% | -$94.2K |
|
2114
Opko Health
OPK
$1.12B
| $374K | ﹤0.01% |
40,171
-71,453
| -64% | -$665K |
|
2115
Build-A-Bear
BBW
$962M
| $372K | ﹤0.01% |
27,055
+6,065
| +29% | +$83.4K |
|
2116
Northrop Grumman
NOC
$83B
| $372K | ﹤0.01% |
1,600
-34,286
| -96% | -$7.97M |
|
|
FGL
2117
DELISTED
Fidelity & Guaranty Life
FGL
| $372K | ﹤0.01% |
+15,710
| New | +$372K |
|
|
AIV
2118
Aimco
AIV
$1.07B
| $371K | ﹤0.01% |
61,225
-66,556
| -52% | -$403K |
|
2119
Oaktree Specialty Lending
OCSL
$1.21B
| $371K | ﹤0.01% |
23,043
-15,904
| -41% | -$256K |
|
2120
Scholastic
SCHL
$660M
| $371K | ﹤0.01% |
7,817
-100
| -1% | -$4.75K |
|
2121
Monro
MNRO
$507M
| $370K | ﹤0.01% |
6,461
-28,365
| -81% | -$1.62M |
|
2122
TherapeuticsMD
TXMD
$12.7M
| $370K | ﹤0.01% |
1,284
-15,707
| -92% | -$4.53M |
|
2123
Gladstone Investment Corp
GAIN
$543M
| $367K | ﹤0.01% |
43,398
+27,426
| +172% | +$232K |
|
2124
Acuity Brands
AYI
$10.1B
| $366K | ﹤0.01% |
+1,584
| New | +$366K |
|
|
BOLD
2125
DELISTED
Audentes Therapeutics, Inc
BOLD
| $366K | ﹤0.01% |
20,008
-12,862
| -39% | -$235K |
|